Ann: Positive IHL-675A in vivo results and FDA Pathway, page-124

MSB was taking a Phase 3 Human Trial.... likely couldve been fast tracked or rushed too.

Rates of failure increase with every stage you go up.

IHL could only need either no human trial or a phase 1 human trial to get EUA from the FDA.

MSB is also a 2 billion dollar company.
IHL is 150M MC.

Massive risk/reward discrepancy here.